HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS

Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome

Al-Seraihy, Amal
Ayas, Mouhab
Al-Nounou, Randa
El-Solh, Hassan
Al-Ahmari, Ali
Al-Jefri, Abdullah
Belgaumi, Asim

September 2011

BACKGROUND AND OBJECTIVESAllogeneic stem cell transplantation (SCT) offers the best chance of cure a...

Autologous haematopoietic stem cell transplantation in childhood solid tumours

Kościelniak, Ewa

November 2000

The data were presented partially at the Conference “Haematopoietic Stem Cell Transplantation in Chi...

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Bartelink, Imke H.
Bredius, Robert G.M.
Belitser, Svetlana V.
Suttorp, Marit M.
Bierings, Marc
Knibbe, Catherijne A.J.
Egeler, Maarten
Lankester, Arjan C.
Egberts, Atoine C.G.
Zwaveling, Juliette
Boelens, Jaap Jan

February 2009

Busulfan, combined with therapeutic drug monitoring-guided dosing, is associated with higher event-f...

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Bartelink, Imke H.
Bredius, Robert G.M.
Belitser, Svetlana V.
Suttorp, Marit M.
Bierings, Marc
Knibbe, Catherijne A.J.
Egeler, Maarten
Lankester, Arjan C.
Egberts, Atoine C.G.
Zwaveling, Juliette
Boelens, Jaap Jan

February 2009

AbstractBusulfan, combined with therapeutic drug monitoring–guided dosing, is associated with higher...

Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia

Xu, L. P.
Zhang, X. H.
Wang, F. R.
Mo, X. D.
Han, T. T.
Han, W.
Chen, Y. H.
Zhang, Y. Y.
Wang, J. Z.
Yan, C. H.
Sun, Y. Q.
Zuo, S. N.
Huang, X. J.

January 2017

Techniques for haploidentical hematopoietic stem cell transplantation (haplo-HSCT) to treat severe a...

Large volume leukapheresis for autologous peripheral blood stem cell collection in children weighting less than 25 kg

Ginani, Valéria Cortez
Cecyn, Karin Zattar
Carvalho, ML
Caran, Eliana Maria Monteiro
Macedo, Carla Renata Pacheco Donato
Gordan, L. N
Gouveia, Roseane Vasconcelos
Bastos, EMSC
Delbuono, Elizabete
Lee, MLM
Oliveira, OMW
Vieira, MJ
Seixas, MT
Petrilli, Antonio Sergio
Seber, Adriana

February 2004

Universidade Federal de São Paulo, GRAACC, Pediat Oncol Inst, São Paulo, BrazilUniversidade Federal ...

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission

BUENO, Nadjanara Dorna
DULLEY, Frederico Luiz
SABOYA, Rosaura
AMIGO FILHO, José Ulysses
CORACIN, Fabio Luiz
CHAMONE, Dalton de Alencar Fischer

January 2011

BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been es...

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies

Kebriaei, Partow
Madden, Timothy
Kazerooni, Reza
Wang, Xuemei
Thall, Peter F.
Ledesma, Celina
Nieto, Yago
Shpall, Elizabeth J.
Hosing, Chitra
Qazilbash, Muzaffar
Popat, Uday
Khouri, Issa
Champlin, Richard E.
Jones, Roy B.
Andersson, Borje S.

March 2011

We investigated the administration of intravenous (i.v.) busulfan (Bu) combined with melphalan (Mel)...

Stem cell transplantation for aplastic anemia and myelodysplastic syndrome

Stary J.
Locatelli F.
Niemeyer C. M.

January 2005

Stem cell transplantation (SCT) from a histocompatible sibling is treatment of choice for severe apl...

Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan

ZECCA M
MASETTI R
BALDUZZI A
FAGIOLI F
DINI G
ROVELLI A
LO NIGRO L
REGAZZI M
PESSION A
PRETE A
LOCATELLI F.
MESSINA, CHIARA
BASSO, GIUSEPPE

January 2009

More than 80% of children with de novo acute myeloid leukemia (AML) achieve complete remission (CR) ...

Favorable Outcome of Hematopoietic Stem Cell Transplantation Using a Targeted Once-Daily Intravenous Busulfan–Fludarabine–Etoposide Regimen in Pediatric and Infant Acute Lymphoblastic Leukemia Patients

Lee, Ji Won
Kang, Hyoung Jin
Kim, Sungjin
Lee, Seung Hwan
Yu, Kyung-Sang
Kim, Nam Hee
Jang, Mi Kyoung
Kim, Hyery
Song, Sang Hoon
Park, June Dong
Park, Kyung Duk
Shin, Hee Young
Jang, In-Jin
Ahn, Hyo Seop

January 2015

AbstractConditioning regimens for pediatric acute lymphoblastic leukemia (ALL) usually include total...

Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes

Locatelli F.
Pession A.
Bonetti F.
Maserati E.
Prete L.
Pedrazzoli P.
Zecca M.
Prete A.
Paolucci P.
Cazzola M.

January 1994

As typical disorders of the elderly, myelodysplastic syndromes (MDSs) are relatively unusual in chil...

Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies

Small, Trudy N.
Young, James W.
Castro-Malaspina, Hugo
Prockop, Susan
Wilton, Andrew
Heller, Glenn
Boulad, Farid
Chiu, Michelle
Hsu, Katherine
Jakubowski, Ann
Kernan, Nancy A.
Perales, Miguel-Angel
O’Reilly, Richard J.
Papadopoulos, Esperanza B.

February 2007

AbstractResults of allogeneic hematopoietic stem cell transplantation (HCT) to treat advanced leukem...

Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.

Locatelli F
Pession A
Bonetti F
Maserati E
Prete L
Pedrazzoli P
Zecca M
Prete A
Paolucci P
Cazzola M

January 1994

As typical disorders of the elderly, myelodysplastic syndromes (MDSs) are relatively unusual in chil...

BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES.

LOCATELLI F.
PESSION A.
BONETTI F.
E. MASERATI
PRETE L.
PEDRAZZOLI P.
ZECCA M.
PRETE A.
PAOLUCCI P.
CAZZOLA M.

January 1994

As typical disorders of the elderly, myelodysplastic syndromes (MDSs) are relatively unusual in chil...

Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome

Al-Seraihy, Amal
Ayas, Mouhab
Al-Nounou, Randa
El-Solh, Hassan
Al-Ahmari, Ali
Al-Jefri, Abdullah
Belgaumi, Asim

September 2011

BACKGROUND AND OBJECTIVESAllogeneic stem cell transplantation (SCT) offers the best chance of cure a...

Autologous haematopoietic stem cell transplantation in childhood solid tumours

Kościelniak, Ewa

November 2000

The data were presented partially at the Conference “Haematopoietic Stem Cell Transplantation in Chi...

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Bartelink, Imke H.
Bredius, Robert G.M.
Belitser, Svetlana V.
Suttorp, Marit M.
Bierings, Marc
Knibbe, Catherijne A.J.
Egeler, Maarten
Lankester, Arjan C.
Egberts, Atoine C.G.
Zwaveling, Juliette
Boelens, Jaap Jan

February 2009

Busulfan, combined with therapeutic drug monitoring-guided dosing, is associated with higher event-f...

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Bartelink, Imke H.
Bredius, Robert G.M.
Belitser, Svetlana V.
Suttorp, Marit M.
Bierings, Marc
Knibbe, Catherijne A.J.
Egeler, Maarten
Lankester, Arjan C.
Egberts, Atoine C.G.
Zwaveling, Juliette
Boelens, Jaap Jan

February 2009

AbstractBusulfan, combined with therapeutic drug monitoring–guided dosing, is associated with higher...

Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia

Xu, L. P.
Zhang, X. H.
Wang, F. R.
Mo, X. D.
Han, T. T.
Han, W.
Chen, Y. H.
Zhang, Y. Y.
Wang, J. Z.
Yan, C. H.
Sun, Y. Q.
Zuo, S. N.
Huang, X. J.

January 2017

Techniques for haploidentical hematopoietic stem cell transplantation (haplo-HSCT) to treat severe a...

Large volume leukapheresis for autologous peripheral blood stem cell collection in children weighting less than 25 kg

Ginani, Valéria Cortez
Cecyn, Karin Zattar
Carvalho, ML
Caran, Eliana Maria Monteiro
Macedo, Carla Renata Pacheco Donato
Gordan, L. N
Gouveia, Roseane Vasconcelos
Bastos, EMSC
Delbuono, Elizabete
Lee, MLM
Oliveira, OMW
Vieira, MJ
Seixas, MT
Petrilli, Antonio Sergio
Seber, Adriana

February 2004

Universidade Federal de São Paulo, GRAACC, Pediat Oncol Inst, São Paulo, BrazilUniversidade Federal ...

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission

BUENO, Nadjanara Dorna
DULLEY, Frederico Luiz
SABOYA, Rosaura
AMIGO FILHO, José Ulysses
CORACIN, Fabio Luiz
CHAMONE, Dalton de Alencar Fischer

January 2011

BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been es...

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies

Kebriaei, Partow
Madden, Timothy
Kazerooni, Reza
Wang, Xuemei
Thall, Peter F.
Ledesma, Celina
Nieto, Yago
Shpall, Elizabeth J.
Hosing, Chitra
Qazilbash, Muzaffar
Popat, Uday
Khouri, Issa
Champlin, Richard E.
Jones, Roy B.
Andersson, Borje S.

March 2011

We investigated the administration of intravenous (i.v.) busulfan (Bu) combined with melphalan (Mel)...

Stem cell transplantation for aplastic anemia and myelodysplastic syndrome

Stary J.
Locatelli F.
Niemeyer C. M.

January 2005

Stem cell transplantation (SCT) from a histocompatible sibling is treatment of choice for severe apl...

Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan

ZECCA M
MASETTI R
BALDUZZI A
FAGIOLI F
DINI G
ROVELLI A
LO NIGRO L
REGAZZI M
PESSION A
PRETE A
LOCATELLI F.
MESSINA, CHIARA
BASSO, GIUSEPPE

January 2009

More than 80% of children with de novo acute myeloid leukemia (AML) achieve complete remission (CR) ...

Favorable Outcome of Hematopoietic Stem Cell Transplantation Using a Targeted Once-Daily Intravenous Busulfan–Fludarabine–Etoposide Regimen in Pediatric and Infant Acute Lymphoblastic Leukemia Patients

Lee, Ji Won
Kang, Hyoung Jin
Kim, Sungjin
Lee, Seung Hwan
Yu, Kyung-Sang
Kim, Nam Hee
Jang, Mi Kyoung
Kim, Hyery
Song, Sang Hoon
Park, June Dong
Park, Kyung Duk
Shin, Hee Young
Jang, In-Jin
Ahn, Hyo Seop

January 2015

AbstractConditioning regimens for pediatric acute lymphoblastic leukemia (ALL) usually include total...

Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes

Locatelli F.
Pession A.
Bonetti F.
Maserati E.
Prete L.
Pedrazzoli P.
Zecca M.
Prete A.
Paolucci P.
Cazzola M.

January 1994

As typical disorders of the elderly, myelodysplastic syndromes (MDSs) are relatively unusual in chil...

Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic Malignancies

Small, Trudy N.
Young, James W.
Castro-Malaspina, Hugo
Prockop, Susan
Wilton, Andrew
Heller, Glenn
Boulad, Farid
Chiu, Michelle
Hsu, Katherine
Jakubowski, Ann
Kernan, Nancy A.
Perales, Miguel-Angel
O’Reilly, Richard J.
Papadopoulos, Esperanza B.

February 2007

AbstractResults of allogeneic hematopoietic stem cell transplantation (HCT) to treat advanced leukem...

Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.

Locatelli F
Pession A
Bonetti F
Maserati E
Prete L
Pedrazzoli P
Zecca M
Prete A
Paolucci P
Cazzola M

January 1994

As typical disorders of the elderly, myelodysplastic syndromes (MDSs) are relatively unusual in chil...

BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES.

LOCATELLI F.
PESSION A.
BONETTI F.
E. MASERATI
PRETE L.
PEDRAZZOLI P.
ZECCA M.
PRETE A.
PAOLUCCI P.
CAZZOLA M.

January 1994

As typical disorders of the elderly, myelodysplastic syndromes (MDSs) are relatively unusual in chil...

Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome

Al-Seraihy, Amal
Ayas, Mouhab
Al-Nounou, Randa
El-Solh, Hassan
Al-Ahmari, Ali
Al-Jefri, Abdullah
Belgaumi, Asim

September 2011

BACKGROUND AND OBJECTIVESAllogeneic stem cell transplantation (SCT) offers the best chance of cure a...

Autologous haematopoietic stem cell transplantation in childhood solid tumours

Kościelniak, Ewa

November 2000

The data were presented partially at the Conference “Haematopoietic Stem Cell Transplantation in Chi...

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Bartelink, Imke H.
Bredius, Robert G.M.
Belitser, Svetlana V.
Suttorp, Marit M.
Bierings, Marc
Knibbe, Catherijne A.J.
Egeler, Maarten
Lankester, Arjan C.
Egberts, Atoine C.G.
Zwaveling, Juliette
Boelens, Jaap Jan

February 2009

Busulfan, combined with therapeutic drug monitoring-guided dosing, is associated with higher event-f...

HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS

Abstract

Extracted data

HIGH DOSE ORAL BUSULFAN and INTRAVENOUS MELPHALAN AS CONDITIONING THERAPY for AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) for the TREATMENT of PEDIATRIC SOLID TUMORS

Abstract

Extracted data

Related items

Related items